http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2138290-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_48255ab8a1fd5c35be6bde0256413dc9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_68dbf14c3dbe38867c8363500748c85b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_377017d0ca43d71c7e388340d1e7472b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dafaedf479596c5cdc5e96649719bd72
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-245
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-265
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-48
filingDate 1998-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1999-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5159e6adbd77b04e54bee51254b73852
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_84c5274e8ee688c807db2df20a444289
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6808da9d7ede10ff2bf494ab9ccbab8c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_54b6fe32f50bcd737ed789c4b9786422
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_76666a2e5f7541fd7dcc0300042a0d63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f292a478c0f85a2b07026129ed49d010
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f063093c04d8a933b89173300d3d82bf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_76b2e35ffbafdaf2609cecd45c698fde
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_375ee1c6514ad6ee9954cb719f4e254c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f0b3fcca81ac15f126905abfd8c62223
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41c51de487f9cdb7c652e68300510edf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_990451b4c78d0efad63b44fc348021d8
publicationDate 1999-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2138290-C1
titleOfInvention Agent for prophylaxis of infectious laryngotracheitis in poultry
abstract FIELD: veterinary pharmacology. SUBSTANCE: an agent for prophylaxis of infectious laryngotracheitis in poultry has viral vaccine from the strain "VNIIBP" and bioprotecting agent - liposomal vesicles based on soybean lecithin taken at amount 40-65 mg/1 ml of vaccine. Vesicles can contain soybean lecithin and/or alpha-tocopherol, and/or cholesterol. After 14 days of a single immunization with the indicated agent the immune response is increased by 4-7% as compared with that in prototype. EFFECT: enhanced effectiveness of immunization. 3 cl, 5 ex
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015189711-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102973668-A
priorityDate 1998-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507953
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14985
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5997
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419552635

Total number of triples: 34.